145 related articles for article (PubMed ID: 21153039)
1. FDG-PET/CT of polymyalgia rheumatica.
Kotani T; Komori T; Kanzaki Y; Takeuchi T; Wakura D; Iimori A; Hirano-Kuwata S; Makino S; Hanafusa T; Ukimura A
Mod Rheumatol; 2011 Jun; 21(3):334-6. PubMed ID: 21153039
[No Abstract] [Full Text] [Related]
2. Various forms of (18)F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica.
Rehak Z; Vasina J; Nemec P; Fojtik Z; Koukalova R; Bortlicek Z; Rehakova D; Adam J; Vavrusova A; Adam Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):629-36. PubMed ID: 26006092
[TBL] [Abstract][Full Text] [Related]
3. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patients with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis.
Yamashita H; Kubota K; Takahashi Y; Minaminoto R; Morooka M; Ito K; Kano T; Kaneko H; Takashima H; Mimoiri A
Mod Rheumatol; 2012 Sep; 22(5):705-11. PubMed ID: 22205118
[TBL] [Abstract][Full Text] [Related]
4. Polymyalgia rheumatica and interspinous FDG uptake on PET/CT.
Adams H; Raijmakers P; Smulders Y
Clin Nucl Med; 2012 May; 37(5):502-5. PubMed ID: 22475905
[TBL] [Abstract][Full Text] [Related]
5. F-18 FDG PET/CT of polymyalgia rheumatica.
Toriihara A; Seto Y; Yoshida K; Umehara I; Nakagawa T; Liu R; Iwamoto I
Clin Nucl Med; 2009 May; 34(5):305-6. PubMed ID: 19387211
[No Abstract] [Full Text] [Related]
6. F-18 FDG PET/CT in giant cell arteritis with polymyalgia rheumatica.
Dos Anjos DA; Dos Anjos RF; de Paula WD; Sobrinho AB
Clin Nucl Med; 2008 Jun; 33(6):402-4. PubMed ID: 18496446
[No Abstract] [Full Text] [Related]
7. Positron emission tomography: the ideal tool in polymyalgia rheumatica?
Wendling D; Blagosklonov O; Boulahdour H; Prati C
Joint Bone Spine; 2014 Oct; 81(5):381-3. PubMed ID: 24962975
[No Abstract] [Full Text] [Related]
8. FDG PET/CT Imaging of Severe Polymyalgia Rheumatica.
Chen J; Wong VCK; Bui C; Mansberg R
Clin Nucl Med; 2023 Jul; 48(7):630-632. PubMed ID: 36928039
[TBL] [Abstract][Full Text] [Related]
9. Occult Hodgkin lymphoma presenting as polymyalgia rheumatica: value of [18F]-FDG positron emission tomography.
Durant C; Hervier B; Ansquer C; Masseau A; Hamidou M
Ann Hematol; 2010 Jan; 89(1):111-2. PubMed ID: 19633848
[No Abstract] [Full Text] [Related]
10. Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica.
Takahashi H; Yamashita H; Kubota K; Miyata Y; Okasaki M; Morooka M; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2015 Jul; 25(4):546-51. PubMed ID: 25401232
[TBL] [Abstract][Full Text] [Related]
11. FDG positron emission tomography of giant cell arteritis with polymyalgia rheumatica.
Shikino K; Ikusaka M; Shimada F
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25762574
[No Abstract] [Full Text] [Related]
12. Similarities and differences in fluorodeoxyglucose positron emission tomography/computed tomography findings in spondyloarthropathy, polymyalgia rheumatica and rheumatoid arthritis.
Yamashita H; Kubota K; Takahashi Y; Minamimoto R; Morooka M; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2013 Mar; 80(2):171-7. PubMed ID: 22749663
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic FDG PET/CT findings in polymyalgia rheumatica.
Otsuka Y; Harada K; Otsuka F
QJM; 2019 Feb; 112(2):139-140. PubMed ID: 30203039
[No Abstract] [Full Text] [Related]
14. Use of
Betrains A; Blockmans D
PET Clin; 2020 Apr; 15(2):147-152. PubMed ID: 32145885
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
Wakura D; Kotani T; Takeuchi T; Komori T; Yoshida S; Makino S; Hanafusa T
PLoS One; 2016; 11(7):e0158509. PubMed ID: 27384410
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic Syndrome Presenting with Polymyalgia Rheumatica-like Accumulations on
Umetsu A; Shimizu T; Iwamoto N; Hashiguchi K; Eguchi M; Okamoto M; Endo Y; Tsuji S; Takatani A; Igawa T; Sumiyoshi R; Koga T; Kawashiri SY; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kawakami A
Intern Med; 2019 Mar; 58(6):861-864. PubMed ID: 30449806
[TBL] [Abstract][Full Text] [Related]
17. Involvement of pubic symphysis in polymyalgia rheumatica: 18-FDG PET/CT evaluation.
Sondag M; Verhoeven F; Prati C; Guillot X; Blagosklonov O; Boulahdour H; Wendling D
Joint Bone Spine; 2017 Oct; 84(5):635-636. PubMed ID: 27838247
[No Abstract] [Full Text] [Related]
18. On the use of
Giraud N; Verhoeven F; Wendling D; Prati C
Joint Bone Spine; 2022 Oct; 89(5):105377. PubMed ID: 35288266
[No Abstract] [Full Text] [Related]
19. Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study.
Moosig F; Czech N; Mehl C; Henze E; Zeuner RA; Kneba M; Schröder JO
Ann Rheum Dis; 2004 Jul; 63(7):870-3. PubMed ID: 15194587
[TBL] [Abstract][Full Text] [Related]
20. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study.
Sondag M; Guillot X; Verhoeven F; Blagosklonov O; Prati C; Boulahdour H; Wendling D
Rheumatology (Oxford); 2016 Aug; 55(8):1452-7. PubMed ID: 27107429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
